Latest S-1 registration statements

Infinity Natural Resources, Inc. has filed an amendment to its Form S-1 registration statement for its initial public offering of Class A common stock.

Smithfield Foods files amended and restated bylaws outlining procedures for shareholder meetings, director nominations, and other corporate governance matters in preparation for its upcoming IPO.

CERo Therapeutics is offering up to 4 million shares of common stock, pre-funded warrants, and common warrants in a new offering.

Blaize Holdings, Inc. has filed a registration statement for the resale of 89,405,192 shares of common stock and 898,250 warrants, alongside the issuance of 29,648,250 shares upon warrant exercise, marking a significant financial restructuring following its recent merger.

Bio-Path Holdings is seeking to raise capital through a public offering of common stock and warrants, while continuing to advance its clinical-stage oncology and obesity-focused drug candidates.

ReShape Lifesciences Inc. has filed a registration statement for a potential offering of up to $3.5 million in common stock, as the company navigates a proposed merger and asset sale.

Archimedes Tech SPAC Partners II Co. has filed an amended S-1 registration statement with the SEC for a $200 million initial public offering, aiming to merge with a technology business.

Bitmine Immersion Technologies formalizes its commitment to ethical business conduct with a newly filed Code of Ethics, applicable to all directors, officers, and employees.

Iron Horse Acquisitions Corp. II, a new blank check company led by experienced SPAC executives, is launching a $250 million initial public offering to pursue business combinations primarily within the media and entertainment industry, with a focus on content studios, film production, family entertainment, animation, music, gaming, e-sports, and talent-facing brands.

Kiromic BioPharma is seeking to raise capital through a public offering of units, each consisting of one share of common stock and a warrant, to further its development of allogeneic Gamma Delta T-cell therapies for solid tumors.

iQSTEL Inc. has filed a registration statement for the potential resale of up to 15,000,000 shares of common stock by a selling shareholder, while also acknowledging substantial doubt about its ability to continue as a going concern.

Expion360 Inc. has filed a registration statement for the resale of up to 1,048,386 shares of common stock issuable upon the exercise of warrants.

Sionna Therapeutics, a clinical-stage biopharmaceutical company, has filed an S-1 registration statement for an initial public offering to fund the development of novel medicines for cystic fibrosis.

Virpax Pharmaceuticals aims to raise capital through a public offering of common stock and pre-funded warrants to fund clinical trials and for general corporate purposes.

Direct Digital Holdings has filed a registration statement for the resale of 8.5 million shares of its Class A common stock by New Circle Principal Investments LLC.

SailPoint, backed by Thoma Bravo, files for an IPO aiming to enhance financial flexibility and market presence while Thoma Bravo is expected to maintain significant control.

N2OFF, Inc. has filed a registration statement for the resale of up to 53,125,000 shares of common stock by selling stockholders, following a recent private placement.

Odyssey Therapeutics, a clinical-stage biopharmaceutical company, has filed an S-1 registration statement for an initial public offering, seeking to advance its pipeline of immunomodulatory therapies.

NewHold Investment Corp III, a blank check company, aims to raise $175 million through an IPO to pursue a business combination in the industrial technology sector.

Damon Inc. has filed a registration statement for the resale of up to 18.5 million common shares by existing securityholders, including Streeterville Capital and Maxim Partners.

AEye Inc. has filed a registration statement for the resale of up to 5,353,710 shares of its common stock by certain selling stockholders.

Catalyst Crew Technologies Corp. is offering 40,000,000 shares of common stock at $0.01 per share to raise capital for its facial recognition technology development.

QT Imaging Holdings has filed a registration statement for the resale of up to 8.8 million shares of its common stock by selling securityholders, following a recent private placement.

Nxu Inc. has filed an amendment to its S-1 registration statement, covering the resale of up to 114.5 million shares of Class A common stock by selling stockholders, as the company navigates a strategic merger with Verde Bioresins.

Thoughtful Media Group has filed an amendment to its S-1 registration statement, detailing its upcoming initial public offering and a concurrent resale offering.

Digital Ally, Inc. has filed an amendment to its registration statement to allow selling stockholders to resell up to 808,377 shares of common stock.

Processa Pharmaceuticals has filed an amendment to its registration statement for a public offering of up to 9,400,705 shares of common stock, pre-funded warrants, and common warrants.

Inflection Point Acquisition Corp. III, a special purpose acquisition company, has filed an amendment to its S-1 registration statement for a proposed $220 million initial public offering.

OneMeta Inc. amends its share acquisition agreement with Metalanguage Corp. and Saul Leal, while also preparing for a public offering and Nasdaq listing.

Soluna Holdings files an amendment to its registration statement for a common stock offering, detailing warrants, agreements with YA II PN, Ltd., and Chuntao Zhou.